Please Wait

Applying Filters...

J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

PIPERACILLIN; TAZOBACTAM

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 14 USDMF, 14 CEP/COS, 13 JDMF, 10 KDMF, 13 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

174 FDF Dossiers, 70 FDA Orange Book, 53 Europe, 13 South Africa, 38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML, INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML, INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 Actylis, 4 Roquette

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 2 Fillers, Diluents & Binders, 1 API Stability Enhancers

DIGITAL CONTENT

32 News #PharmaBuzz

32 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 51 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

6 APIs, 5 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 7 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Aurobindo Pharma Limited	India	M/s. Apitoria Pharma Private Limited	WC-0121	Piperacillin and Tazobactam for Injection (8:1) (Bulk Drug) USP	2022-08-02	2025-07-02	Plot No. 68-70, 73-91, 95, 96, 260, 261, IDA, Pashamylaram (village), Patancheru (Mandal), Sangareddy District, Pincode ?502307, Telangana, India
09/06/2025	Rajasthan Antibiotics	India	M/s. Rajasthan Antibiotics Ltd	WC-0420	Piperacillin Sodium and Tazobactam (8.1) IH Sterile	2024-04-23	2027-04-01	Plot no. A-619 & 630, RIICO Industrial Area, Bhiwadi -301019, Dist -Alwar, Rajasthan.

Contact us
to update this info

PIPERACILLIN; TAZOBACTAM

PIPERACILLIN; TAZOBACTAM

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

46 API Suppliers

14 USDMF

14 CEP/COS

13 JDMF

10 KDMF

13 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

174 FDF Dossiers

70 FDA Orange Book

53 Europe

13 South Africa

38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML

INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML

INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 Actylis

4 Roquette

EXCIPIENTS BY APPLICATIONS

3 Parenteral

2 Fillers, Diluents & Binders

1 API Stability Enhancers

DIGITAL CONTENT

32 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

51 Regulatory FDF Prices

5 Annual Reports

MARKET PLACE

6 APIs

5 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

4 USP

7 Others

Filters

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons